buy doxycycline

Comparison of azithromycin and doxycycline in the treatment of rectal chlamydia

Rectal chlamydia is a frequent sexually transmitted infection in men who have sex with men. Despite the high prevalence of the infection, there are no clear recommendations for its treatment, which is due to the insufficient number of randomized trials.


A double-blind study including men who have sex with men and have asymptomatic rectal chlamydia was performed.

Inclusion in the study took place in 5 clinics in Australia.

Patients were randomized to doxycycline 100 mg twice daily for 7 days or azithromycin 1 g (single dose).

It is noted that the asymptomatic patient population was not chosen randomly, 85% of patients with rectal chlamydia have an asymptomatic course. According to clinical guidelines, therapy of symptomatic infection is longer.

The primary endpoint A negative rectal chlamydia test result (microbiological cure) at 4 weeks was chosen.


  • From August 2016 to August 2019, the study included 625 men randomized to doxycycline and azithromycin at a 1:1 ratio.
  • Microbiological cure was observed in 96.9% of patients receiving doxycycline, compared with 76.4% of patients receiving azithromycin. The difference between the groups reached 19.9%.
  • According to the safety analysis, side effects such as diarrhea, nausea and vomiting occurred in 33.8% of patients in the doxycycline group and 45.1% of patients in the azithromycin group. The difference between the groups was 11.3%.


A 7-day course of doxycycline is superior to a single dose of azithromycin in the treatment of asymptomatic rectal chlamydia in men who have sex with men.

Source: Andrew Lau, Fabian Y.S. Kong, Christopher K. Fairley, et al.

The information and materials presented on this site are for research, reference and analytical purposes only for healthcare professionals, are not intended to market products and should not be relied upon as advice or recommendations to patients regarding the use of any medication or treatment without consulting with your physician.

drugs, information about which is contained on this site, have contraindications, before using them you should read the instructions and consult a specialist.

The opinion of the Administration does not necessarily reflect the opinion of the authors and lecturers. The administration makes no warranty with respect to the site or its content, including, without limitation, the scientific value, relevance, accuracy, completeness, reliability of scientific data presented by lecturers or compliance of the content with international standards of good clinical practice and. The site assumes no responsibility for any recommendations or opinions that may be contained, nor for the applicability of the site materials to specific clinical situations. All scientific information is provided in its original form, with no guarantee of completeness or timeliness. Administration makes every effort to provide users with accurate and reliable information, but at the same time does not exclude the possibility of errors.